Literature DB >> 33636428

HCV virology and diagnosis.

Steven Roger1, Alexandra Ducancelle1, Hélène Le Guillou-Guillemette1, Catherine Gaudy2, Françoise Lunel3.   

Abstract

Hepatitis C virus (HCV) infection is a major cause of severe liver disease including chronic hepatitis, cirrhosis and hepatocellular carcinoma. The HCV burden in public health is estimated at about 71 million people worldwide by World Health Organization (WHO) with at least 400,000 people that died every year from HCV disease [1]. New hepatitis C treatments with oral direct-acting antivirals (DAAs) showing high rates of response, with short treatment duration [2] have been available. HCV can now be eradicated with minimal side effects. Unfortunately, there is no vaccine yet available, but the development of a safe prophylactic vaccine remains a medical priority [3]. For this purpose, Hepatitis B-C subviral envelope particles can be produced by industrialized procedure. It seems to be very promising as this HBV-HCV vaccine candidate has been shown to elicit a broadly cross neutralizing activity against HCV [4]. Despite this revolution in the HCV-treatment, one of major challenge to achieve a global eradication of HCV remains to reduce the under diagnosis. The low rate of diagnosis is a major obstacle in resources limited countries and is mainly due to the cost of molecular tools, that are essential to diagnose and follow chronic HCV infection. In another hand, the mild clinical symptoms observed in HCV chronic disease, may explain that the majority of HCV infected individuals are unaware of their infection, because HCV testing is not generalized, like it is for HIV. HCV was discovered in 1989 after many years of work, by several researchers, who recently obtained the Nobel price [5-7]. This major discovery allowed the description of the HCV genome and later on of the virus replication and cell cycle, and also, importantly, the development of diagnostic tests for the detection of HCV antibodies (Ab) and RNA who were a priority in transfusion. In this review, we will try to get into the virology and cell biology of HCV. Thereafter, we will discuss the different categories of laboratory tests to diagnose/explore HCV infected subjects.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Diagnosis; Hepatitis C virus; Virology

Mesh:

Substances:

Year:  2021        PMID: 33636428     DOI: 10.1016/j.clinre.2021.101626

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  8 in total

1.  RT-LAMP-Based Molecular Diagnostic Set-Up for Rapid Hepatitis C Virus Testing.

Authors:  Sandhya Sharma; Emmanuel Thomas; Massimo Caputi; Waseem Asghar
Journal:  Biosensors (Basel)       Date:  2022-05-05

2.  Rapid Visual Detection of Hepatitis C Virus Using Reverse Transcription Recombinase-Aided Amplification-Lateral Flow Dipstick.

Authors:  Haili Wang; Yuhang Zhang; Jingming Zhou; Ming Li; Yumei Chen; Yankai Liu; Hongliang Liu; Peiyang Ding; Chao Liang; Xifang Zhu; Ying Zhang; Cheng Xin; Gaiping Zhang; Aiping Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-17       Impact factor: 5.293

Review 3.  Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses.

Authors:  Yannick Tréguier; Anne Bull-Maurer; Philippe Roingeard
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

Review 4.  The potential roles of interleukin-25 in infectious diseases.

Authors:  Jing Wu; Fang Zhang; Hongji Tao; Waqas Nawaz; Deyan Chen; Zhiwei Wu
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

5.  The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis.

Authors:  Ru Xu; Xia Rong; Elihu Aranday-Cortes; Sreenu Vattipally; Joseph Hughes; John McLauchlan; Yongshui Fu
Journal:  Viruses       Date:  2022-07-11       Impact factor: 5.818

6.  Hepatitis C Virus Evades Interferon Signaling by Suppressing Long Noncoding RNA Linc-Pint Involving C/EBP-β.

Authors:  Mousumi Khatun; Jinsong Zhang; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

7.  Characterization of a Novel Hepatitis C Subtype, 6xj, and Its Consequences for Direct-Acting Antiviral Treatment in Yunnan, China.

Authors:  Yuanyuan Jia; Wei Yue; Qinghua Gao; Rui Tao; Yaxiang Zhang; Xiaoyang Fu; Yang Liu; Li Liu; Yue Feng; Xueshan Xia
Journal:  Microbiol Spectr       Date:  2021-08-25

Review 8.  Insight into the Evolving Role of PCSK9.

Authors:  Mateusz Maligłówka; Michał Kosowski; Marcin Hachuła; Marcin Cyrnek; Łukasz Bułdak; Marcin Basiak; Aleksandra Bołdys; Grzegorz Machnik; Rafał Jakub Bułdak; Bogusław Okopień
Journal:  Metabolites       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.